×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GYRE – gyre therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GYRE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/5
07:19 am
gyre
Gyre Therapeutics Announces Alignment with China's CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting [Yahoo! Finance]
High
Report
Gyre Therapeutics Announces Alignment with China's CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting [Yahoo! Finance]
1/5
07:00 am
gyre
Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting
High
Report
Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting
11/18
07:20 am
gyre
Gyre Therapeutics (NASDAQ:GYRE) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
Gyre Therapeutics (NASDAQ:GYRE) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/10
06:58 am
gyre
Is Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) ROE Of 8.6% Concerning? [Yahoo! Finance]
Low
Report
Is Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) ROE Of 8.6% Concerning? [Yahoo! Finance]
11/7
06:00 am
gyre
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update
Medium
Report
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update
10/18
07:31 am
gyre
Gyre Therapeutics (NASDAQ:GYRE) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Gyre Therapeutics (NASDAQ:GYRE) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/9
04:01 pm
gyre
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Zhang Ping
Medium
Report
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Zhang Ping
1/9
04:01 pm
gyre
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Chen Ruoyu
Medium
Report
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Chen Ruoyu
1/5
07:06 am
gyre
Form 8-K GYRE THERAPEUTICS, INC. For: Jan 05
High
Report
Form 8-K GYRE THERAPEUTICS, INC. For: Jan 05
11/13
08:32 pm
gyre
Form 144 GYRE THERAPEUTICS, INC. Filed by: Ye Weiguo
Low
Report
Form 144 GYRE THERAPEUTICS, INC. Filed by: Ye Weiguo
11/7
04:16 pm
gyre
Form 10-Q GYRE THERAPEUTICS, INC. For: Sep 30
Medium
Report
Form 10-Q GYRE THERAPEUTICS, INC. For: Sep 30
11/7
06:05 am
gyre
Form 8-K GYRE THERAPEUTICS, INC. For: Nov 07
Medium
Report
Form 8-K GYRE THERAPEUTICS, INC. For: Nov 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: